Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate for HIV latency reversal in adults with suppressed HIV-1 on ART
NL-OMON60650Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topiramate in human immunodeficiency virus infection (HIV), sponsored by Erasmus MC. Primary endpoints: Fold change in cell-associated HIV-1 RNA after topiramate and Safety and tolerability. Started Jul 2024; status: recruiting.
02
Drugs
topiramate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON60650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60650.